The sale would thereafter be known as "the weeping time." The owner of the slaves, Pierce Butler, had inherited the family's Georgia plantations some twenty years earlier, along with his brother John.

f you’ve never seen the oddly beautiful springtime of the Gobi Desert or the mildly nauseating glisten of a newly born camel, “The Story of the Weeping Camel” can guarantee at least two new pleasures.

Eli Lilly just shared some new information. That data suggests it has an advantage against Novo Nordisk in a key market. It'll take a while for the economic implications of the data to play out.

NEW DELHI: Eli Lilly, the US pharmaceutical giant that gained widespread attention globally with its weight-loss treatments, plans to launch its blockbuster drug - Tirzepatide - in India in 2025.

Eli Lilly and Company (NYSE: LLY) today announced results from the Phase 3 EMBER-3 study of imlunestrant, an investigational, oral selective estrogen receptor degrader (SERD), in patients with ...

Mounjaro, manufactured by Lilly, may have emerged as the newest and most effective treatment option after a victory over Novo Nordisk’s Ozempic in clinical trials. For some patients, injectables ...

Telehealth firm Ro has partnered with Eli Lilly And Co (NYSE:LLY) to enhance patient access to Zepbound (tirzepatide) single-dose vials for obesity treatment. Through LillyDirect, Ro will provide ...

Serving on the board at Allegheny Valley Association of Churches and the Alle-Kiski Area HOPE... New Kensington man sentenced in kidnapping case called 'a single woman's worst nightmare' A New ...

Eli Lilly has said it is prepared to invest £279 million ($364 million) in the UK and work with the government to tackle serious public health challenges, including obesity. The proposal ...

Filled with the top stories to start your day, and emergency news alerts.

“Should we fail to achieve a fair and equitable resolution, I plan to donate the remaining lease term to a church, synagogue, or registered Connecticut nonprofit organization,” Ron Spector said in a ...